Global Therapeutic Nuclear Medicines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Therapeutic Nuclear Medicines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.



Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.

According to our (Global Info Research) latest study, the global Therapeutic Nuclear Medicines market size was valued at US$ 2055 million in 2023 and is forecast to a readjusted size of USD 6310 million by 2030 with a CAGR of 17.6% during review period.

Global Therapeutic Nuclear Medicines key players include Bayer, Novartis AG, China Isotope & Radiation, etc. Global top three manufacturers hold a share over 75%.

North America is the largest market, with a share about 45%, followed by Europe and Asia-Pacific, both have a share about 50 percent.

In terms of product, Radium-223 is the largest segment, with a share over 45%. And in terms of application, the largest application is Thyroid, followed by Bone Metastasis.

This report is a detailed and comprehensive analysis for global Therapeutic Nuclear Medicines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Therapeutic Nuclear Medicines market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030

Global Therapeutic Nuclear Medicines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030

Global Therapeutic Nuclear Medicines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030

Global Therapeutic Nuclear Medicines market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Therapeutic Nuclear Medicines

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Therapeutic Nuclear Medicines market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis AG, Bayer, China Isotope & Radiation, Q BioMed, Curium Pharmaceuticals, Jubilant DraxImage, Dongcheng, Lantheus, Acrotech Biopharma., Progenics Pharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Therapeutic Nuclear Medicines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Radium-223
Lutetium-177
Iodine-131
Other

Market segment by Application
Thyroid
Bone Metastasis
Lymphoma
Other

Major players covered
Novartis AG
Bayer
China Isotope & Radiation
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Dongcheng
Lantheus
Acrotech Biopharma.
Progenics Pharmaceuticals
International Isotopes

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Therapeutic Nuclear Medicines product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Therapeutic Nuclear Medicines, with price, sales quantity, revenue, and global market share of Therapeutic Nuclear Medicines from 2019 to 2024.

Chapter 3, the Therapeutic Nuclear Medicines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Therapeutic Nuclear Medicines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Therapeutic Nuclear Medicines market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Therapeutic Nuclear Medicines.

Chapter 14 and 15, to describe Therapeutic Nuclear Medicines sales channel, distributors, customers, research findings and conclusion.